Zentalis Pharmaceuticals financial statements

젠테일스 파머슈티컬NASDAQ:ZNTL · Nasdaq · Healthcare · sector #17
$2.67-3.96%
2026-10-06 close

Zentalis Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $67M. 2024 operating profit was −$191M.

Reported results

Zentalis Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q